Salvatore G. Viscomi

Each episode, we dig into the eureka moment behind their innovation, the wider problem it's solving, and its potential impact on the future of healthcare.

Today, we're joined by Dr. Salvatore Viscomi, CEO and co-founder of Karner Health.

KANA is an AI-driven platform built to detect, manage, and prevent Cardio Kidney Metabolic Syndrome.

In just the past year, they've secured funding, landed a spot on Fortune's Most Innovative Companies list, and launched pilots reaching 35,000 people in Cameroon.